MUTZ-8Homo sapiens (Human)Cancer cell line

Also known as: Menschliche Und Tierische Zellkulture-8, MUTZ8

🤖 AI SummaryBased on 3 publications

Quick Overview

MUTZ-8 is a human AML cell line with 5q deletion and JAK2 mutation.

Detailed Summary

MUTZ-8 is a human acute myeloid leukemia (AML) cell line derived from a patient with a history of myelodysplastic syndrome (MDS). It is characterized by a specific chromosomal deletion of 5q31 and a JAK2 V617F mutation. This cell line exhibits cytokine dependency, requiring external growth factors for proliferation. It shows sensitivity to JAK2 inhibition, making it a valuable tool for studying the role of JAK2 mutations in myeloproliferative disorders. MUTZ-8 is also notable for its unique cytogenetic features, including a non-reciprocal translocation t(5,11)(q21,10), which contributes to its distinct genetic profile. The cell line's responsiveness to various cytokines and its genetic alterations make it a useful model for researching AML and MDS pathogenesis.

Research Applications

Study of JAK2 V617F mutation in myeloproliferative disordersInvestigation of 5q31 deletion in AML/MDSCytokine signaling and response profilingModel for JAK2 inhibitor sensitivity

Key Characteristics

Cytokine-dependent proliferationJAK2 V617F mutation5q31 deletionNon-reciprocal translocation t(5,11)(q21,10)Sensitivity to JAK2 inhibition
Generated on 6/18/2025

Basic Information

Database IDCVCL_2130
SpeciesHomo sapiens (Human)
Tissue SourcePeripheral blood[UBERON:UBERON_0000178]

Donor Information

Age63
Age CategoryAdult
SexFemale

Disease Information

DiseaseAcute myeloid leukemia
LineageMyeloid
SubtypeAcute Myeloid Leukemia
OncoTree CodeAML

DepMap Information

Source TypeDSMZ
Source IDACH-001577_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleJAK2p.Val617Phe (c.1849G>T)Homozygous-from parent cell line UKE-1

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
11
D13S317
9,11
D16S539
12
D18S51
12,15
D19S433
13,15
D21S11
28,29
D2S1338
17,23
D3S1358
16
D5S818
12
D7S820
11
D8S1179
14
FGA
18,20
Penta D
13,15
Penta E
12,20
TH01
9,9.3
TPOX
8,9
vWA
18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.

Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.

Leukemia 20:471-476(2006).

New acute myeloid leukemia-derived cell line: MUTZ-8 with 5q-.";

Hu Z.-B., MacLeod R.A.F., Meyer C., Quentmeier H., Drexler H.G.

Leukemia 16:1556-1561(2002).

Establishment of the two cytokine-dependent acute myeloid leukemia-derived cell lines MUTZ-8 and MUTZ-11.

Hu Z.-B., Quentmeier H., Meyer C., MacLeod R.A.F., Drexler H.G.

(In book chapter) Acute leukemias IX. Haematology and blood transfusion, Vol. 41; Hiddemann W., Haferlach T., Unterhalt M., Buechner T., Ritter J. (eds.); pp.122-127; Springer; Berlin; Germany (2003).

Web Resources